Engineered immune cells take on advanced bladder cancer in new trial

NCT ID NCT03185468

Recruiting now Disease control Sponsor: Shenzhen Geno-Immune Medical Institute Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 23 times

Summary

This study tests a new treatment called 4SCAR-T cells for people with advanced bladder cancer that has spread and has no other treatment options. The therapy uses a patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The trial aims to see if this approach is safe and can help control the disease. About 20 participants will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shenzhen Geno-immune Medical Institute
RECRUITING

Shenzhen, Guangdong, 518000, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Shenzhen Second People Hospital
RECRUITING

Shenzhen, Gongdong, China

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BLADDER CANCER UROTHELIAL CARCINOMA BLADDER